Rank | Gene Set | Z-score |
---|---|---|
1 | signal peptide processing (GO:0006465) | 7.64980822 |
2 | * Golgi transport vesicle coating (GO:0048200) | 6.45896287 |
3 | * COPI coating of Golgi vesicle (GO:0048205) | 6.45896287 |
4 | GDP-mannose metabolic process (GO:0019673) | 5.41238822 |
5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.41054382 |
6 | protein retention in ER lumen (GO:0006621) | 4.96705022 |
7 | protein maturation by protein folding (GO:0022417) | 4.69563176 |
8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.50325736 |
9 | ATP synthesis coupled proton transport (GO:0015986) | 4.25043701 |
10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.25043701 |
11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.22147871 |
12 | respiratory chain complex IV assembly (GO:0008535) | 4.13776464 |
13 | COPII vesicle coating (GO:0048208) | 4.02840333 |
14 | protein complex biogenesis (GO:0070271) | 3.99870051 |
15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.97105204 |
16 | cytidine deamination (GO:0009972) | 3.96332457 |
17 | cytidine metabolic process (GO:0046087) | 3.96332457 |
18 | cytidine catabolic process (GO:0006216) | 3.96332457 |
19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.89641047 |
20 | cytochrome complex assembly (GO:0017004) | 3.87976263 |
21 | nucleotide transmembrane transport (GO:1901679) | 3.86172894 |
22 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.71861236 |
23 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.70380917 |
24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.68845556 |
25 | respiratory electron transport chain (GO:0022904) | 3.67459041 |
26 | regulation of mitochondrial translation (GO:0070129) | 3.64443738 |
27 | electron transport chain (GO:0022900) | 3.62267840 |
28 | DNA deamination (GO:0045006) | 3.60749893 |
29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.57979891 |
30 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.55204181 |
31 | cotranslational protein targeting to membrane (GO:0006613) | 3.54339874 |
32 | ER overload response (GO:0006983) | 3.54107380 |
33 | mannosylation (GO:0097502) | 3.53045623 |
34 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.52240114 |
35 | ribosomal small subunit assembly (GO:0000028) | 3.51868275 |
36 | protein targeting to ER (GO:0045047) | 3.50126901 |
37 | sequestering of metal ion (GO:0051238) | 3.50113515 |
38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.48590540 |
39 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.48590540 |
40 | NADH dehydrogenase complex assembly (GO:0010257) | 3.48590540 |
41 | peptidyl-histidine modification (GO:0018202) | 3.48511343 |
42 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.47379645 |
43 | protein localization to endoplasmic reticulum (GO:0070972) | 3.43767327 |
44 | NIK/NF-kappaB signaling (GO:0038061) | 3.43506584 |
45 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.41800511 |
46 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.38566540 |
47 | exocrine pancreas development (GO:0031017) | 3.36645720 |
48 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.35880802 |
49 | proteasome assembly (GO:0043248) | 3.34394060 |
50 | peptide hormone processing (GO:0016486) | 3.32410264 |
51 | cullin deneddylation (GO:0010388) | 3.31308047 |
52 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.30528735 |
53 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.27513047 |
54 | endocrine pancreas development (GO:0031018) | 3.26246774 |
55 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.25328691 |
56 | actin nucleation (GO:0045010) | 3.22001486 |
57 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.21793825 |
58 | protein deneddylation (GO:0000338) | 3.20789734 |
59 | peptidyl-asparagine modification (GO:0018196) | 3.20468609 |
60 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.12181202 |
61 | regulation of oxidative phosphorylation (GO:0002082) | 3.10513612 |
62 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.09205291 |
63 | protein N-linked glycosylation (GO:0006487) | 3.07007975 |
64 | viral protein processing (GO:0019082) | 3.06750193 |
65 | negative regulation of B cell apoptotic process (GO:0002903) | 3.03508456 |
66 | oxidative phosphorylation (GO:0006119) | 3.02950799 |
67 | amino acid salvage (GO:0043102) | 2.99587628 |
68 | L-methionine salvage (GO:0071267) | 2.99587628 |
69 | L-methionine biosynthetic process (GO:0071265) | 2.99587628 |
70 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.96726088 |
71 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.95359656 |
72 | response to interferon-beta (GO:0035456) | 2.94114399 |
73 | iron-sulfur cluster assembly (GO:0016226) | 2.92078433 |
74 | metallo-sulfur cluster assembly (GO:0031163) | 2.92078433 |
75 | T cell apoptotic process (GO:0070231) | 2.92048986 |
76 | GMP metabolic process (GO:0046037) | 2.92016768 |
77 | immunoglobulin mediated immune response (GO:0016064) | 2.89634817 |
78 | glandular epithelial cell differentiation (GO:0002067) | 2.89116792 |
79 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.86023097 |
80 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.85648287 |
81 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.85648287 |
82 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.84352638 |
83 | response to misfolded protein (GO:0051788) | 2.81948201 |
84 | viral mRNA export from host cell nucleus (GO:0046784) | 2.80387232 |
85 | positive regulation of lamellipodium organization (GO:1902745) | 2.79378863 |
86 | nuclear envelope reassembly (GO:0031468) | 2.79127389 |
87 | mitotic nuclear envelope reassembly (GO:0007084) | 2.79127389 |
88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.78926976 |
89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78491665 |
90 | positive regulation of B cell differentiation (GO:0045579) | 2.78324008 |
91 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.77975413 |
92 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.77051820 |
93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.76771269 |
94 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.75502578 |
95 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.74945171 |
96 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74269704 |
97 | regulation of superoxide anion generation (GO:0032928) | 2.73254166 |
98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73012192 |
99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73012192 |
100 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73012192 |
101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72862936 |
102 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72862936 |
103 | chaperone-mediated protein transport (GO:0072321) | 2.72525529 |
104 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71843373 |
105 | negative regulation of ligase activity (GO:0051352) | 2.71843373 |
106 | pyrimidine-containing compound salvage (GO:0008655) | 2.71833504 |
107 | pyrimidine nucleoside salvage (GO:0043097) | 2.71833504 |
108 | proline biosynthetic process (GO:0006561) | 2.71481018 |
109 | translation (GO:0006412) | 2.67554427 |
110 | nucleotide-sugar metabolic process (GO:0009225) | 2.66970328 |
111 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.66804878 |
112 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.66804878 |
113 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66719633 |
114 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.66585684 |
115 | pentose-phosphate shunt (GO:0006098) | 2.66523210 |
116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65989519 |
117 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.65548342 |
118 | deoxyribonucleotide catabolic process (GO:0009264) | 2.65143295 |
119 | regulation of defense response to virus by virus (GO:0050690) | 2.65050608 |
120 | cell redox homeostasis (GO:0045454) | 2.64424978 |
121 | heme biosynthetic process (GO:0006783) | 2.64377001 |
122 | peptide metabolic process (GO:0006518) | 2.63445884 |
123 | GPI anchor biosynthetic process (GO:0006506) | 2.63184069 |
124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62194826 |
125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.61854016 |
126 | virion assembly (GO:0019068) | 2.61740176 |
127 | GTP biosynthetic process (GO:0006183) | 2.60438733 |
128 | purine nucleotide salvage (GO:0032261) | 2.59660386 |
129 | barbed-end actin filament capping (GO:0051016) | 2.59522739 |
130 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.58721239 |
131 | nucleoside diphosphate catabolic process (GO:0009134) | 2.57082946 |
132 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56988844 |
133 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56988844 |
134 | positive regulation of nuclease activity (GO:0032075) | 2.56906935 |
135 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.54940934 |
136 | amyloid precursor protein catabolic process (GO:0042987) | 2.53580453 |
137 | deoxyribose phosphate catabolic process (GO:0046386) | 2.53515570 |
138 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53172930 |
139 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.53130522 |
140 | pentose metabolic process (GO:0019321) | 2.51840218 |
141 | UV protection (GO:0009650) | 2.51594285 |
142 | negative regulation of stress fiber assembly (GO:0051497) | 2.50128365 |
143 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49574429 |
144 | nucleotide salvage (GO:0043173) | 2.49571738 |
145 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48968566 |
146 | pinocytosis (GO:0006907) | 2.48677635 |
147 | cellular response to interferon-beta (GO:0035458) | 2.48392528 |
148 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.42505780 |
149 | NADH metabolic process (GO:0006734) | 2.42284316 |
150 | regulation of metalloenzyme activity (GO:0048552) | 2.41591986 |
151 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.41388595 |
152 | lymphocyte apoptotic process (GO:0070227) | 2.41031883 |
153 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.40523852 |
154 | establishment of viral latency (GO:0019043) | 2.39195654 |
155 | regulation of mitochondrial membrane potential (GO:0051881) | 2.38577944 |
156 | negative regulation of cell size (GO:0045792) | 2.38189262 |
157 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.36885259 |
158 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.36593453 |
159 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.36543715 |
160 | positive thymic T cell selection (GO:0045059) | 2.36451065 |
161 | glucose catabolic process (GO:0006007) | 2.35698678 |
162 | cellular response to type I interferon (GO:0071357) | 2.35007577 |
163 | type I interferon signaling pathway (GO:0060337) | 2.35007577 |
164 | amino sugar catabolic process (GO:0046348) | 2.33049829 |
165 | negative regulation of viral genome replication (GO:0045071) | 2.32802016 |
166 | leukocyte apoptotic process (GO:0071887) | 2.30655726 |
167 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.30519280 |
168 | extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) | 2.27871105 |
169 | response to type I interferon (GO:0034340) | 2.27676555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.33813916 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.67042491 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.49710721 |
4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.09739592 |
5 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.89987665 |
6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.73062071 |
7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.19415620 |
8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.13859946 |
9 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.09024847 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05578502 |
11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.87164555 |
12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.79253467 |
13 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.77276179 |
14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.76364451 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.71017499 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69747546 |
17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64506709 |
18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.54443927 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43834183 |
20 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.40740834 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29755890 |
22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29690407 |
23 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25555808 |
24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.24722760 |
25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23626221 |
26 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.20368553 |
27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17848258 |
28 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16639508 |
29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14059361 |
30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13803746 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12896181 |
32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.11666208 |
33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.09818521 |
34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.09442994 |
35 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.06337139 |
36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.02621126 |
37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.99036523 |
38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95980982 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91269233 |
40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90447768 |
41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89180216 |
42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.88000868 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85601117 |
44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84858519 |
45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.84147995 |
46 | MYC_22102868_ChIP-Seq_BL_Human | 1.78370900 |
47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77403635 |
48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76525980 |
49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71905989 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62867515 |
51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61601221 |
52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60057106 |
53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58912898 |
54 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57908361 |
55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57558341 |
56 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55313413 |
57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55064198 |
58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.53973333 |
59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53753631 |
60 | P68_20966046_ChIP-Seq_HELA_Human | 1.53264534 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53007838 |
62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49610852 |
63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47323146 |
64 | MAF_26560356_Chip-Seq_TH1_Human | 1.44531035 |
65 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.43527203 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43183963 |
67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41672422 |
68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40230240 |
69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.40106375 |
70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40054340 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.39547340 |
72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.36589218 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34590713 |
74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34389778 |
75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34216297 |
76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.33439144 |
77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33235217 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32816313 |
79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31691795 |
80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30639124 |
81 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29556024 |
82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27149859 |
83 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25750074 |
84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25590809 |
85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24614882 |
86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24396603 |
87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23098198 |
88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22539747 |
89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20841241 |
90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19895999 |
91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19771373 |
92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16542912 |
93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16446159 |
94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16105927 |
95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14079396 |
96 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.13599928 |
97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13523151 |
98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13180337 |
99 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12803461 |
100 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11863203 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09978494 |
102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09126988 |
103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08784593 |
104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08164738 |
105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.07800144 |
106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07495795 |
107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07207958 |
108 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.06372926 |
109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06308454 |
110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04610573 |
111 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03907925 |
112 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02337363 |
113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02108591 |
114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01722028 |
115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01691234 |
116 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01662402 |
117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01614690 |
118 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01461067 |
119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.01361948 |
120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99649811 |
121 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99064023 |
122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98622620 |
123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98253732 |
124 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95053833 |
125 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.92256629 |
126 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91824317 |
127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91610461 |
128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90799316 |
129 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90601452 |
130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89970182 |
131 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89912725 |
132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88038784 |
133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87963613 |
134 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85539391 |
135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85162947 |
136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84364049 |
137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83347064 |
138 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82771140 |
139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81770565 |
140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81451096 |
141 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80396002 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003195_calcinosis | 3.52487876 |
2 | MP0010386_abnormal_urinary_bladder | 3.35639669 |
3 | MP0004043_abnormal_pH_regulation | 3.19770805 |
4 | MP0005220_abnormal_exocrine_pancreas | 3.12359424 |
5 | MP0003183_abnormal_peptide_metabolism | 3.07471870 |
6 | MP0005451_abnormal_body_composition | 2.86206022 |
7 | MP0002693_abnormal_pancreas_physiology | 2.84518662 |
8 | MP0003283_abnormal_digestive_organ | 2.83830811 |
9 | MP0000013_abnormal_adipose_tissue | 2.70835370 |
10 | MP0002877_abnormal_melanocyte_morpholog | 2.55135019 |
11 | MP0005379_endocrine/exocrine_gland_phen | 2.52538026 |
12 | MP0006082_CNS_inflammation | 2.46534192 |
13 | MP0001944_abnormal_pancreas_morphology | 2.41062386 |
14 | MP0001986_abnormal_taste_sensitivity | 2.37994150 |
15 | MP0005058_abnormal_lysosome_morphology | 2.31117777 |
16 | MP0005084_abnormal_gallbladder_morpholo | 2.30165665 |
17 | MP0001873_stomach_inflammation | 2.29849198 |
18 | MP0003806_abnormal_nucleotide_metabolis | 2.28446809 |
19 | MP0003303_peritoneal_inflammation | 2.26599049 |
20 | MP0005464_abnormal_platelet_physiology | 2.23694974 |
21 | MP0002909_abnormal_adrenal_gland | 2.21338949 |
22 | MP0000678_abnormal_parathyroid_gland | 2.18521213 |
23 | MP0002876_abnormal_thyroid_physiology | 2.10847629 |
24 | MP0000465_gastrointestinal_hemorrhage | 2.08268732 |
25 | MP0003763_abnormal_thymus_physiology | 2.07453894 |
26 | MP0005646_abnormal_pituitary_gland | 2.02824346 |
27 | MP0003075_altered_response_to | 1.98975764 |
28 | MP0003186_abnormal_redox_activity | 1.96957429 |
29 | MP0003724_increased_susceptibility_to | 1.94665864 |
30 | MP0002638_abnormal_pupillary_reflex | 1.94589907 |
31 | MP0001764_abnormal_homeostasis | 1.93159098 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.90754683 |
33 | MP0002452_abnormal_antigen_presenting | 1.90360976 |
34 | MP0001800_abnormal_humoral_immune | 1.90188992 |
35 | MP0002837_dystrophic_cardiac_calcinosis | 1.80936393 |
36 | MP0002148_abnormal_hypersensitivity_rea | 1.77687735 |
37 | MP0000858_altered_metastatic_potential | 1.77320541 |
38 | MP0005636_abnormal_mineral_homeostasis | 1.76518461 |
39 | MP0009278_abnormal_bone_marrow | 1.73170948 |
40 | MP0001666_abnormal_nutrient_absorption | 1.72480161 |
41 | MP0005365_abnormal_bile_salt | 1.72247435 |
42 | MP0009785_altered_susceptibility_to | 1.71575808 |
43 | MP0005083_abnormal_biliary_tract | 1.69816955 |
44 | MP0001853_heart_inflammation | 1.69542653 |
45 | MP0004510_myositis | 1.69135263 |
46 | MP0009643_abnormal_urine_homeostasis | 1.66176305 |
47 | MP0000343_altered_response_to | 1.66013265 |
48 | MP0002163_abnormal_gland_morphology | 1.65745094 |
49 | MP0005671_abnormal_response_to | 1.64356118 |
50 | MP0006054_spinal_hemorrhage | 1.63992469 |
51 | MP0001835_abnormal_antigen_presentation | 1.61061059 |
52 | MP0000716_abnormal_immune_system | 1.58001720 |
53 | MP0002398_abnormal_bone_marrow | 1.57365280 |
54 | MP0005408_hypopigmentation | 1.53501322 |
55 | MP0000372_irregular_coat_pigmentation | 1.52815793 |
56 | MP0010155_abnormal_intestine_physiology | 1.51781880 |
57 | MP0004947_skin_inflammation | 1.50219644 |
58 | MP0000604_amyloidosis | 1.48647033 |
59 | MP0002722_abnormal_immune_system | 1.48619522 |
60 | MP0009780_abnormal_chondrocyte_physiolo | 1.48603975 |
61 | MP0002429_abnormal_blood_cell | 1.45367503 |
62 | MP0003300_gastrointestinal_ulcer | 1.42582020 |
63 | MP0002139_abnormal_hepatobiliary_system | 1.42008299 |
64 | MP0003866_abnormal_defecation | 1.41868999 |
65 | MP0003172_abnormal_lysosome_physiology | 1.41533125 |
66 | MP0002078_abnormal_glucose_homeostasis | 1.39849086 |
67 | MP0003329_amyloid_beta_deposits | 1.39130161 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.38835085 |
69 | MP0004782_abnormal_surfactant_physiolog | 1.37543214 |
70 | MP0005166_decreased_susceptibility_to | 1.36483948 |
71 | MP0000681_abnormal_thyroid_gland | 1.36390479 |
72 | MP0002405_respiratory_system_inflammati | 1.34674806 |
73 | MP0000689_abnormal_spleen_morphology | 1.33985127 |
74 | MP0004858_abnormal_nervous_system | 1.32359135 |
75 | MP0009764_decreased_sensitivity_to | 1.27011932 |
76 | MP0001905_abnormal_dopamine_level | 1.26030993 |
77 | MP0005075_abnormal_melanosome_morpholog | 1.23917918 |
78 | MP0002933_joint_inflammation | 1.23254915 |
79 | MP0000613_abnormal_salivary_gland | 1.22024050 |
80 | MP0005310_abnormal_salivary_gland | 1.21867607 |
81 | MP0003122_maternal_imprinting | 1.20964569 |
82 | MP0003693_abnormal_embryo_hatching | 1.20930972 |
83 | MP0005025_abnormal_response_to | 1.20579503 |
84 | MP0004147_increased_porphyrin_level | 1.20176525 |
85 | MP0001756_abnormal_urination | 1.18924365 |
86 | MP0000703_abnormal_thymus_morphology | 1.18864723 |
87 | MP0001529_abnormal_vocalization | 1.18804207 |
88 | MP0000490_abnormal_crypts_of | 1.18447698 |
89 | MP0003436_decreased_susceptibility_to | 1.16564312 |
90 | MP0001542_abnormal_bone_strength | 1.14857442 |
91 | MP0001664_abnormal_digestion | 1.10679199 |
92 | MP0005387_immune_system_phenotype | 1.09464406 |
93 | MP0001790_abnormal_immune_system | 1.09464406 |
94 | MP0001765_abnormal_ion_homeostasis | 1.08942225 |
95 | MP0003786_premature_aging | 1.08903378 |
96 | MP0005000_abnormal_immune_tolerance | 1.08672993 |
97 | MP0006072_abnormal_retinal_apoptosis | 1.07456361 |
98 | MP0001727_abnormal_embryo_implantation | 1.06030245 |
99 | MP0002419_abnormal_innate_immunity | 1.05874346 |
100 | MP0008469_abnormal_protein_level | 1.05687931 |
101 | MP0002132_abnormal_respiratory_system | 1.05275748 |
102 | MP0005360_urolithiasis | 1.05069344 |
103 | MP0005397_hematopoietic_system_phenotyp | 1.03804520 |
104 | MP0001545_abnormal_hematopoietic_system | 1.03804520 |
105 | MP0002019_abnormal_tumor_incidence | 1.03673135 |
106 | MP0009763_increased_sensitivity_to | 1.01861860 |
107 | MP0003959_abnormal_lean_body | 1.01600106 |
108 | MP0001845_abnormal_inflammatory_respons | 1.00991903 |
109 | MP0005165_increased_susceptibility_to | 1.00773362 |
110 | MP0005645_abnormal_hypothalamus_physiol | 1.00497950 |
111 | MP0005332_abnormal_amino_acid | 1.00297796 |
112 | MP0009333_abnormal_splenocyte_physiolog | 0.98573291 |
113 | MP0001533_abnormal_skeleton_physiology | 0.98254190 |
114 | MP0003448_altered_tumor_morphology | 0.96694734 |
115 | MP0002938_white_spotting | 0.95710709 |
116 | MP0000538_abnormal_urinary_bladder | 0.92024301 |
117 | MP0002277_abnormal_respiratory_mucosa | 0.90870647 |
118 | MP0003953_abnormal_hormone_level | 0.90803200 |
119 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89742608 |
120 | MP0001663_abnormal_digestive_system | 0.89697561 |
121 | MP0006276_abnormal_autonomic_nervous | 0.89527827 |
122 | MP0008438_abnormal_cutaneous_collagen | 0.89399060 |
123 | MP0008260_abnormal_autophagy | 0.89045068 |
124 | MP0009379_abnormal_foot_pigmentation | 0.88689423 |
125 | MP0009840_abnormal_foam_cell | 0.86928907 |
126 | MP0008004_abnormal_stomach_pH | 0.86782762 |
127 | MP0005390_skeleton_phenotype | 0.86570557 |
128 | MP0000230_abnormal_systemic_arterial | 0.85247976 |
129 | MP0003656_abnormal_erythrocyte_physiolo | 0.85196325 |
130 | MP0000003_abnormal_adipose_tissue | 0.84538410 |
131 | MP0000750_abnormal_muscle_regeneration | 0.81938761 |
132 | MP0008874_decreased_physiological_sensi | 0.81086754 |
133 | MP0002723_abnormal_immune_serum | 0.80787823 |
134 | MP0009642_abnormal_blood_homeostasis | 0.79086671 |
135 | MP0002234_abnormal_pharynx_morphology | 0.78395720 |
136 | MP0003191_abnormal_cellular_cholesterol | 0.77646099 |
137 | MP0002138_abnormal_hepatobiliary_system | 0.77274202 |
138 | MP0005501_abnormal_skin_physiology | 0.76083982 |
139 | MP0002420_abnormal_adaptive_immunity | 0.76015846 |
140 | MP0005319_abnormal_enzyme/_coenzyme | 0.75820667 |
141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75307745 |
142 | MP0008873_increased_physiological_sensi | 0.74449678 |
143 | MP0001819_abnormal_immune_cell | 0.74393734 |
144 | MP0005330_cardiomyopathy | 0.73939845 |
145 | MP0003111_abnormal_nucleus_morphology | 0.73312591 |
146 | MP0001188_hyperpigmentation | 0.72544838 |
147 | MP0000313_abnormal_cell_death | 0.71514579 |
148 | MP0000685_abnormal_immune_system | 0.71460457 |
149 | MP0000358_abnormal_cell_content/ | 0.69105742 |
150 | MP0003868_abnormal_feces_composition | 0.68429701 |
151 | MP0002998_abnormal_bone_remodeling | 0.68163995 |
152 | MP0006035_abnormal_mitochondrial_morpho | 0.67628695 |
153 | MP0005666_abnormal_adipose_tissue | 0.67129773 |
154 | MP0008007_abnormal_cellular_replicative | 0.66833624 |
155 | MP0003453_abnormal_keratinocyte_physiol | 0.64286086 |
156 | MP0008932_abnormal_embryonic_tissue | 0.63878014 |
157 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63293588 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hepatic necrosis (HP:0002605) | 4.54069898 |
2 | Increased IgM level (HP:0003496) | 4.53901689 |
3 | Acute necrotizing encephalopathy (HP:0006965) | 4.44009313 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.33882712 |
5 | Hepatocellular necrosis (HP:0001404) | 4.32721502 |
6 | Mitochondrial inheritance (HP:0001427) | 4.30962233 |
7 | Type I transferrin isoform profile (HP:0003642) | 4.25676795 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 3.95912769 |
9 | Acute encephalopathy (HP:0006846) | 3.93782208 |
10 | Hypoglycemic seizures (HP:0002173) | 3.78686883 |
11 | Hypoglycemic coma (HP:0001325) | 3.73819017 |
12 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.68978758 |
13 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.68978758 |
14 | Abnormal protein glycosylation (HP:0012346) | 3.68978758 |
15 | Abnormal glycosylation (HP:0012345) | 3.68978758 |
16 | Increased CSF lactate (HP:0002490) | 3.68260718 |
17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.66509274 |
18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.66509274 |
19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.66509274 |
20 | Symptomatic seizures (HP:0011145) | 3.54707547 |
21 | Autoimmune hemolytic anemia (HP:0001890) | 3.49352761 |
22 | Abnormality of macrophages (HP:0004311) | 3.42404824 |
23 | Vacuolated lymphocytes (HP:0001922) | 3.41638947 |
24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.34898651 |
25 | Generalized aminoaciduria (HP:0002909) | 3.31542562 |
26 | Progressive macrocephaly (HP:0004481) | 3.28017825 |
27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.26958814 |
28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.26958814 |
29 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15435279 |
30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.10365307 |
31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04962360 |
32 | Obstructive lung disease (HP:0006536) | 3.04962360 |
33 | Hypothermia (HP:0002045) | 3.01773460 |
34 | Vertebral compression fractures (HP:0002953) | 2.98885067 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96222264 |
36 | Cholecystitis (HP:0001082) | 2.93143225 |
37 | Abnormal gallbladder physiology (HP:0012438) | 2.93143225 |
38 | Reduced antithrombin III activity (HP:0001976) | 2.88361698 |
39 | Agammaglobulinemia (HP:0004432) | 2.85183984 |
40 | Mediastinal lymphadenopathy (HP:0100721) | 2.84382527 |
41 | Lactic acidosis (HP:0003128) | 2.83356399 |
42 | Ragged-red muscle fibers (HP:0003200) | 2.83329353 |
43 | Recurrent abscess formation (HP:0002722) | 2.77034134 |
44 | Eczematoid dermatitis (HP:0000976) | 2.76450230 |
45 | Granulocytopenia (HP:0001913) | 2.70102411 |
46 | Hypergammaglobulinemia (HP:0010702) | 2.68320386 |
47 | Neuroendocrine neoplasm (HP:0100634) | 2.68264873 |
48 | Cellulitis (HP:0100658) | 2.62836820 |
49 | Renal Fanconi syndrome (HP:0001994) | 2.61722314 |
50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61341980 |
51 | Purpura (HP:0000979) | 2.60499167 |
52 | Hepatosplenomegaly (HP:0001433) | 2.59324298 |
53 | Exercise intolerance (HP:0003546) | 2.58764968 |
54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58516857 |
55 | Pheochromocytoma (HP:0002666) | 2.57825492 |
56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57502353 |
57 | Urticaria (HP:0001025) | 2.56043282 |
58 | Increased serum lactate (HP:0002151) | 2.54953154 |
59 | Respiratory failure (HP:0002878) | 2.53036608 |
60 | Increased muscle lipid content (HP:0009058) | 2.52911167 |
61 | Meningitis (HP:0001287) | 2.51503935 |
62 | Cerebral edema (HP:0002181) | 2.50059555 |
63 | Hypertensive crisis (HP:0100735) | 2.49873977 |
64 | Increased serum ferritin (HP:0003281) | 2.49394511 |
65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49305396 |
66 | Recurrent bacterial skin infections (HP:0005406) | 2.48239597 |
67 | Ketoacidosis (HP:0001993) | 2.45257494 |
68 | Late onset (HP:0003584) | 2.43172541 |
69 | Dysostosis multiplex (HP:0000943) | 2.40397210 |
70 | Abnormality of urine glucose concentration (HP:0011016) | 2.39692244 |
71 | Glycosuria (HP:0003076) | 2.39692244 |
72 | Prolonged neonatal jaundice (HP:0006579) | 2.38893603 |
73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34469025 |
74 | Mucopolysacchariduria (HP:0008155) | 2.34469025 |
75 | Abnormality of T cell physiology (HP:0011840) | 2.33384531 |
76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.29868732 |
77 | Rough bone trabeculation (HP:0100670) | 2.28435128 |
78 | Eosinophilia (HP:0001880) | 2.27541269 |
79 | Increased cerebral lipofuscin (HP:0011813) | 2.27056639 |
80 | Beaking of vertebral bodies (HP:0004568) | 2.26641632 |
81 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23171535 |
82 | Abnormality of T cell number (HP:0011839) | 2.21694404 |
83 | Systemic lupus erythematosus (HP:0002725) | 2.20900701 |
84 | Dicarboxylic aciduria (HP:0003215) | 2.18170563 |
85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18170563 |
86 | Loss of speech (HP:0002371) | 2.16036143 |
87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.14545663 |
88 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.14545663 |
89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14300833 |
90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13653481 |
91 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.12268816 |
92 | True hermaphroditism (HP:0010459) | 2.11998569 |
93 | Progressive neurologic deterioration (HP:0002344) | 2.11159720 |
94 | Aplastic anemia (HP:0001915) | 2.09867337 |
95 | J-shaped sella turcica (HP:0002680) | 2.08835949 |
96 | Opisthotonus (HP:0002179) | 2.07025337 |
97 | Optic disc pallor (HP:0000543) | 2.06554474 |
98 | Myositis (HP:0100614) | 2.06133706 |
99 | CNS demyelination (HP:0007305) | 2.05391479 |
100 | Hyperphosphaturia (HP:0003109) | 2.05007498 |
101 | Decreased circulating renin level (HP:0003351) | 2.04782296 |
102 | Abnormality of T cells (HP:0002843) | 2.04739632 |
103 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04138746 |
104 | Achilles tendon contracture (HP:0001771) | 2.03877701 |
105 | Increased IgE level (HP:0003212) | 2.02851225 |
106 | Premature skin wrinkling (HP:0100678) | 2.02696339 |
107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01142742 |
108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01142742 |
109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01142742 |
110 | Exertional dyspnea (HP:0002875) | 1.99343736 |
111 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99217752 |
112 | Axonal loss (HP:0003447) | 1.98572556 |
113 | Abnormality of renal resorption (HP:0011038) | 1.98104201 |
114 | Distal lower limb muscle weakness (HP:0009053) | 1.97737778 |
115 | Glucose intolerance (HP:0000833) | 1.95580818 |
116 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95473747 |
117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95235785 |
118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95122013 |
119 | Microvesicular hepatic steatosis (HP:0001414) | 1.94610378 |
120 | Large for gestational age (HP:0001520) | 1.94425767 |
121 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93359900 |
122 | Recurrent viral infections (HP:0004429) | 1.92455452 |
123 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92339005 |
124 | Emotional lability (HP:0000712) | 1.91971892 |
125 | Stomatitis (HP:0010280) | 1.91631913 |
126 | Thrombocytosis (HP:0001894) | 1.90550551 |
127 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.90473294 |
128 | Poor head control (HP:0002421) | 1.89708435 |
129 | Irregular vertebral endplates (HP:0003301) | 1.89209912 |
130 | Medial flaring of the eyebrow (HP:0010747) | 1.87810940 |
131 | Palpitations (HP:0001962) | 1.87805499 |
132 | Skin rash (HP:0000988) | 1.87385721 |
133 | Leukodystrophy (HP:0002415) | 1.87344010 |
134 | Abnormality of glycolysis (HP:0004366) | 1.87281823 |
135 | Increased serum pyruvate (HP:0003542) | 1.87281823 |
136 | Methylmalonic aciduria (HP:0012120) | 1.85562986 |
137 | Vasculitis (HP:0002633) | 1.84959322 |
138 | Pancreatic fibrosis (HP:0100732) | 1.84426689 |
139 | Petechiae (HP:0000967) | 1.84197050 |
140 | Amyloidosis (HP:0011034) | 1.84114498 |
141 | Hyperglycemia (HP:0003074) | 1.83601100 |
142 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83342921 |
143 | Cholelithiasis (HP:0001081) | 1.82324976 |
144 | Abnormality of the Achilles tendon (HP:0005109) | 1.82048742 |
145 | Recurrent fungal infections (HP:0002841) | 1.81895367 |
146 | Neoplasm of the adrenal gland (HP:0100631) | 1.80558817 |
147 | Microretrognathia (HP:0000308) | 1.79349059 |
148 | Cerebral palsy (HP:0100021) | 1.78301061 |
149 | Abnormality of iron homeostasis (HP:0011031) | 1.77826977 |
150 | Neutropenia (HP:0001875) | 1.77538957 |
151 | Lethargy (HP:0001254) | 1.77362387 |
152 | Disproportionate short-trunk short stature (HP:0003521) | 1.74769406 |
153 | Hypochromic anemia (HP:0001931) | 1.74581515 |
154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73661957 |
155 | Growth hormone excess (HP:0000845) | 1.72864821 |
156 | Rhabdomyolysis (HP:0003201) | 1.72428468 |
157 | Myopathic facies (HP:0002058) | 1.72400574 |
158 | Epiphyseal stippling (HP:0010655) | 1.71816999 |
159 | Abnormal pupillary function (HP:0007686) | 1.71511662 |
160 | Hypertriglyceridemia (HP:0002155) | 1.71498139 |
161 | Testicular atrophy (HP:0000029) | 1.70986014 |
162 | Long palpebral fissure (HP:0000637) | 1.70648892 |
163 | Acute hepatic failure (HP:0006554) | 1.69963773 |
164 | Dysautonomia (HP:0002459) | 1.69840395 |
165 | Orthostatic hypotension (HP:0001278) | 1.69389639 |
166 | Abnormal trabecular bone morphology (HP:0100671) | 1.69283395 |
167 | Encephalitis (HP:0002383) | 1.69141953 |
168 | Sepsis (HP:0100806) | 1.68679632 |
169 | Upper limb amyotrophy (HP:0009129) | 1.67742937 |
170 | Distal upper limb amyotrophy (HP:0007149) | 1.67742937 |
171 | Poor suck (HP:0002033) | 1.67442348 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK16 | 4.03176403 |
2 | BCKDK | 3.03472518 |
3 | MAPK15 | 3.00166394 |
4 | PASK | 2.80820267 |
5 | ERN1 | 2.76175869 |
6 | INSRR | 2.75428196 |
7 | IRAK4 | 2.66238476 |
8 | IRAK3 | 2.61665055 |
9 | NME2 | 2.46102391 |
10 | EIF2AK3 | 2.44758439 |
11 | VRK2 | 2.34787110 |
12 | MAP3K12 | 2.31188706 |
13 | PIM2 | 2.21377404 |
14 | NME1 | 2.18828497 |
15 | ARAF | 2.09309104 |
16 | MYLK | 2.08198621 |
17 | SMG1 | 1.90090704 |
18 | BUB1 | 1.88190502 |
19 | TAOK2 | 1.86352825 |
20 | PIK3CG | 1.84854717 |
21 | TRIB3 | 1.68815768 |
22 | WNK4 | 1.65161825 |
23 | TSSK6 | 1.60442852 |
24 | PRPF4B | 1.59900400 |
25 | VRK1 | 1.58216882 |
26 | BRAF | 1.52074664 |
27 | GRK6 | 1.45804032 |
28 | FLT3 | 1.44008119 |
29 | TESK1 | 1.43609615 |
30 | IRAK1 | 1.41279032 |
31 | ZAP70 | 1.27033891 |
32 | TAOK3 | 1.18826200 |
33 | MST4 | 1.16787288 |
34 | TBK1 | 1.15953472 |
35 | EIF2AK1 | 1.14638449 |
36 | BRSK2 | 1.07827459 |
37 | LIMK1 | 1.07413066 |
38 | MAP3K2 | 1.07247432 |
39 | TEC | 1.05838889 |
40 | ADRBK2 | 1.03379790 |
41 | CAMKK2 | 1.03012123 |
42 | HIPK2 | 1.02796520 |
43 | PBK | 1.01738777 |
44 | MAPKAPK3 | 0.98827215 |
45 | PAK4 | 0.98825628 |
46 | TESK2 | 0.98516752 |
47 | KDR | 0.98454851 |
48 | RIPK4 | 0.98145731 |
49 | EPHA2 | 0.97706083 |
50 | BLK | 0.96459499 |
51 | IKBKE | 0.95607819 |
52 | AKT3 | 0.94549419 |
53 | BMPR2 | 0.93378311 |
54 | AURKA | 0.90098079 |
55 | BMPR1B | 0.88767159 |
56 | TXK | 0.88291183 |
57 | MAP3K14 | 0.85597023 |
58 | CDK19 | 0.84940966 |
59 | BTK | 0.83676960 |
60 | FES | 0.82240459 |
61 | KIT | 0.81323112 |
62 | MAP2K2 | 0.79658507 |
63 | MAP3K11 | 0.79559843 |
64 | ACVR1B | 0.79525940 |
65 | CASK | 0.78724284 |
66 | MUSK | 0.77560078 |
67 | STK10 | 0.76160949 |
68 | CSNK1G3 | 0.75304985 |
69 | LRRK2 | 0.75232495 |
70 | WNK3 | 0.74876763 |
71 | TAOK1 | 0.74604384 |
72 | SYK | 0.74385471 |
73 | PRKCI | 0.74269287 |
74 | MAP2K6 | 0.74101913 |
75 | GRK7 | 0.72977382 |
76 | MAP4K1 | 0.72757436 |
77 | ILK | 0.72400938 |
78 | IRAK2 | 0.72081295 |
79 | LMTK2 | 0.71016778 |
80 | MAP3K6 | 0.70891354 |
81 | MAP3K3 | 0.69756231 |
82 | PAK1 | 0.69599806 |
83 | CCNB1 | 0.69438210 |
84 | BCR | 0.69038406 |
85 | MAPKAPK5 | 0.68915271 |
86 | JAK3 | 0.68879298 |
87 | ZAK | 0.68520378 |
88 | MOS | 0.68494565 |
89 | TYK2 | 0.64964053 |
90 | OBSCN | 0.64664280 |
91 | NLK | 0.64485795 |
92 | SIK1 | 0.63651339 |
93 | DAPK1 | 0.63377393 |
94 | TNIK | 0.63023150 |
95 | ICK | 0.60997591 |
96 | MAP2K3 | 0.60558658 |
97 | PIK3CA | 0.60507500 |
98 | MATK | 0.59797066 |
99 | MAP3K1 | 0.58951973 |
100 | EPHB1 | 0.58469115 |
101 | PRKG2 | 0.58318919 |
102 | TNK2 | 0.57705450 |
103 | PRKCE | 0.56130582 |
104 | CSK | 0.56095808 |
105 | CDK8 | 0.54691722 |
106 | CSF1R | 0.54598978 |
107 | LCK | 0.54366474 |
108 | BRSK1 | 0.53797891 |
109 | MAPK11 | 0.52528555 |
110 | MAP3K5 | 0.51630880 |
111 | PRKD2 | 0.51589347 |
112 | PRKCH | 0.51493510 |
113 | SIK3 | 0.51052368 |
114 | MAP3K8 | 0.51043971 |
115 | TLK1 | 0.49529348 |
116 | CSNK1A1L | 0.47838725 |
117 | IKBKB | 0.47258585 |
118 | SCYL2 | 0.47002321 |
119 | RPS6KB2 | 0.46554891 |
120 | LYN | 0.45642223 |
121 | ADRBK1 | 0.45477458 |
122 | CAMK2D | 0.45048567 |
123 | MAP2K7 | 0.44923107 |
124 | MAPKAPK2 | 0.43890809 |
125 | EEF2K | 0.42883850 |
126 | PTK2 | 0.42451131 |
127 | ABL2 | 0.41785162 |
128 | MAPK12 | 0.41184307 |
129 | NEK6 | 0.40792218 |
130 | RPS6KA5 | 0.40771531 |
131 | CSNK2A1 | 0.40666568 |
132 | RPS6KA6 | 0.40463090 |
133 | PDPK1 | 0.40280266 |
134 | TGFBR2 | 0.39130503 |
135 | PRKD1 | 0.39051639 |
136 | EPHA3 | 0.37967365 |
137 | UHMK1 | 0.37118134 |
138 | ITK | 0.36521501 |
139 | CAMK2G | 0.36388561 |
140 | RPS6KC1 | 0.35693369 |
141 | RPS6KL1 | 0.35693369 |
142 | DYRK2 | 0.35639493 |
143 | CDK14 | 0.35383333 |
144 | DAPK3 | 0.35322344 |
145 | PRKCD | 0.35018526 |
146 | RET | 0.34692633 |
147 | RAF1 | 0.34513501 |
148 | CDK11A | 0.33688073 |
149 | GRK5 | 0.32108102 |
150 | CDK7 | 0.31518486 |
151 | HCK | 0.30056506 |
152 | PIM1 | 0.29840019 |
153 | CDK15 | 0.29549683 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 6.38248011 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.40342719 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.59525853 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.29413616 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.89301691 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.84373393 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40525410 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32349668 |
9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.29141904 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28349587 |
11 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.24527852 |
12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23340007 |
13 | Ribosome_Homo sapiens_hsa03010 | 2.14879744 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.05707246 |
15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.95004510 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.91612554 |
17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88104495 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86939481 |
19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77156367 |
20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.75922041 |
21 | Shigellosis_Homo sapiens_hsa05131 | 1.69832376 |
22 | Salmonella infection_Homo sapiens_hsa05132 | 1.57554189 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56789132 |
24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.56531046 |
25 | RNA polymerase_Homo sapiens_hsa03020 | 1.49789760 |
26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46973062 |
27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42790818 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36607840 |
29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35964768 |
30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35391086 |
31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33278414 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31426360 |
33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29915613 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28962012 |
35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25527615 |
36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23085451 |
37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22219587 |
38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.18213285 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.17692680 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.17646783 |
41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13919345 |
42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13007941 |
43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12412598 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11690782 |
45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11127316 |
46 | Asthma_Homo sapiens_hsa05310 | 1.08648397 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08220910 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06949967 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06583076 |
50 | Measles_Homo sapiens_hsa05162 | 1.04308794 |
51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02955588 |
52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99683040 |
53 | Tuberculosis_Homo sapiens_hsa05152 | 0.99015462 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98663059 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98627964 |
56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95766837 |
57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95506465 |
58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94811770 |
59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93994023 |
60 | Influenza A_Homo sapiens_hsa05164 | 0.93369483 |
61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90944624 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90687786 |
63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89374752 |
64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88546935 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88035949 |
66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87723632 |
67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86993660 |
68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86641939 |
69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86292322 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85159031 |
71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85060222 |
72 | Peroxisome_Homo sapiens_hsa04146 | 0.84196144 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.80763404 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.80567645 |
75 | Pertussis_Homo sapiens_hsa05133 | 0.79685717 |
76 | Malaria_Homo sapiens_hsa05144 | 0.78769187 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78512393 |
78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77733442 |
79 | Purine metabolism_Homo sapiens_hsa00230 | 0.75960663 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.74827903 |
81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73673060 |
82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73337767 |
83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72420702 |
84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71046523 |
85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70857637 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70389863 |
87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68568287 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68339593 |
89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67925898 |
90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67816825 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67644605 |
92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67418444 |
93 | Base excision repair_Homo sapiens_hsa03410 | 0.66975939 |
94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66221207 |
95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65886424 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.65214607 |
97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64999597 |
98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64346305 |
99 | Hepatitis B_Homo sapiens_hsa05161 | 0.59005390 |
100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57791150 |
101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56939962 |
102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56857032 |
103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55382871 |
104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54959636 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54345431 |
106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54344288 |
107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54053633 |
108 | DNA replication_Homo sapiens_hsa03030 | 0.53414779 |
109 | Insulin secretion_Homo sapiens_hsa04911 | 0.52656635 |
110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52161644 |
111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51656093 |
112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51591607 |
113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50554894 |
114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48275133 |
115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47580275 |
116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47382890 |
117 | Hepatitis C_Homo sapiens_hsa05160 | 0.47274789 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46232709 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45500513 |
120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45497670 |
121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44866381 |
122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44309151 |
123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41323035 |
124 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40552419 |
125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39746747 |
126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39733164 |
127 | Mismatch repair_Homo sapiens_hsa03430 | 0.38976503 |
128 | RNA degradation_Homo sapiens_hsa03018 | 0.38002740 |
129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37116022 |
130 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36604961 |
131 | Spliceosome_Homo sapiens_hsa03040 | 0.35319249 |
132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34127545 |
133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.31806210 |
134 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31451607 |
135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31305723 |
136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31286524 |
137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31089521 |
138 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30211325 |
139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30107949 |
140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29995183 |
141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29871441 |
142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29761251 |
143 | Homologous recombination_Homo sapiens_hsa03440 | 0.29434282 |
144 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27917370 |
145 | Prion diseases_Homo sapiens_hsa05020 | 0.26483771 |
146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25922649 |
147 | Allograft rejection_Homo sapiens_hsa05330 | 0.24524959 |